The trademark application LEVAXAN was filed by Dr. Willmar Schwabe GmbH & Co. KG, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on September 18, 2018, and it was registered by office on December 26, 2018 without any oppositions.
The application was filed in German (English was selected as the second language).